Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind, Randomized, Active Drug Comparative, Parallel Designed, Multi-center,Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of "Meditoxin® Versus Botox® in the Treatment of Glabellar Lines

NCT01237977 is registered in ClinicalTrials.gov with Medy-Tox as lead sponsor.

NCT NCT01237977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01237977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind, Randomized, Active Drug Comparative, Parallel Designed, Multi-center,Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of "Meditoxin® Versus Botox® in the Treatment of Glabellar Lines
Lead sponsor
Medy-Tox
Phase
Phase 3
Overall status
Completed
Start date
November 23, 2009
Completion date
September 30, 2010
Enrollment
314 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

skin aging